MARX Biotech Co (ROCO:7731) Long-Term Debt: NT$164.2 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7731 MARX Biotech Co Ltd ROCO:7731
6 GF Score
Price NT$4.76
! 5 Warning Signs
View Full Analysis

What is MARX Biotech Co Long-Term Debt?

MARX Biotech Co ROCO:7731 +6.97% 6 Long-Term Debt is NT$164.2 Mil as of Dec. 2025. GuruFocus rates ROCO:7731 with a GF Score™ of 6/100. The stock has 5 warning signs investors should review.

MARX Biotech Co's Long-Term Debt for the quarter that ended in Dec. 2025 was NT$164.2 Mil.

MARX Biotech Co's quarterly Long-Term Debt increased from Dec. 2024 (NT$165.0 Mil) to Jun. 2025 (NT$171.7 Mil) but then declined from Jun. 2025 (NT$171.7 Mil) to Dec. 2025 (NT$164.2 Mil).

MARX Biotech Co's annual Long-Term Debt increased from Dec. 2023 (NT$0.0 Mil) to Dec. 2024 (NT$165.0 Mil) but then declined from Dec. 2024 (NT$165.0 Mil) to Dec. 2025 (NT$164.2 Mil).

MARX Biotech Co  (ROCO:7731) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

MARX Biotech Co Long-Term Debt Related Terms

MARX Biotech Co Long-Term Debt Historical Data

* Premium members only.

The historical data trend for MARX Biotech Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MARX Biotech Co Long-Term Debt Chart

MARX Biotech Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial 0.00 0.00 0.00 165.04 164.17

MARX Biotech Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 165.04 171.69 164.17
ROCO:7731
6GF Score
MARX Biotech Co Ltd ROCO:7731
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of NT$164.2 Mil mean?
MARX Biotech Co (ROCO:7731) has a Long-Term Debt of NT$164.2 Mil as of Dec. 2025.
Is MARX Biotech Co's Long-Term Debt too high?
MARX Biotech Co's current Long-Term Debt is NT$164.2 Mil. Overall, MARX Biotech Co has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does MARX Biotech Co's Long-Term Debt compare to competitors?
MARX Biotech Co's Long-Term Debt of NT$164.2 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. MARX Biotech Co's current Long-Term Debt is NT$164.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MARX Biotech Co stock overvalued right now?
MARX Biotech Co (ROCO:7731) has a current Long-Term Debt of NT$164.2 Mil. The current Long-Term Debt is NT$164.2 Mil. MARX Biotech Co's overall GF Score™ is 6/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For MARX Biotech Co (ROCO:7731), the current Long-Term Debt is NT$164.2 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MARX Biotech Co Business Description

Address 5th Floor, No. 655, Bannan Road, Zhonghe district, New Taipei, TWN
MARX Biotech Co Ltd is a retail company which has developed an O2O and OMO full-channel layout in the online Internet platform and cosmeceutical retail market, and has successfully established itself in the market and Build trust and operational growth on the channel side. It has has established more than three thousand large and small cosmeceutical pharmacies in Taiwan, including: Dashu Pharmacy, Dingding Pharmacy, Cosmed, Watsons, Spring Pharmacy, New Gaoqiao Pharmacy, Anlier Pharmacies, etc.
6GF Score

Get the complete analysis for ROCO:7731

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$4.76
Price